← Leaderboards
Isaac A Kinde
Papgene, Inc.
$2,281,216
Attributed
$2,281,216
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2016–17$2M$1.5M$1M$500K$0
'16
'17
Funding mix
By agency
NIH$2,281,216 · 1
By mechanism
R44$2,281,216 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Abnormal Cell”
- Gregory H Reaman · National Childhood Cancer Foundation$153,699,445
- Curtis L Meinert · Johns Hopkins University$34,204,161
- Donald Ym Leung · University Of Colorado Denver$33,206,945
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$31,681,596
- Jennifer A Pietenpol · Vanderbilt University$30,444,938
- Richard C Boucher · University Of North Carolina Chapel Hill$30,433,735
Research focus
Abnormal CellDna Sequence AlterationAdvanced DevelopmentAwardApplications GrantsBiopsyBrca1 GeneBrca2 GeneCalibrationCancer DetectionCancer DiagnosticsBaseCellsCellular MorphologyCessation Of LifeClia CertifiedClinical SensitivityCohortCommercializationContractorCouplingCytologyDetectionEarly Diagnosis
Grant awards (4)
Genetic Cytology for Ovarian and Endometrial Cancer Screening$910,751
R44 · FY2017 · CA · contact PI
Genetic Cytology for Ovarian and Endometrial Cancer Screening$83,802
R44 · FY2017 · CA · contact PI
Genetic Cytology for Ovarian and Endometrial Cancer Screening$989,879
R44 · FY2016 · CA · contact PI
Genetic Cytology for Ovarian and Endometrial Cancer Screening$296,784
R44 · FY2016 · CA · contact PI